Foghorn Therapeutics expects about 65 employees after reduction
FHTX•Foghorn Therapeutics expects to have about 65 full-time employees after a workforce reduction and estimates $2.30 million in charges in the fourth quarter of 2026.
FHTX•FHTX•FHTX•Foghorn Therapeutics expects to have about 65 full-time employees after a workforce reduction and estimates $2.30 million in charges in the fourth quarter of 2026.
Foghorn Therapeutics said in an SEC filing that it expects to have about 65 full-time employees after the reduction. The company estimates $2.30 million in one-time severance and benefit costs in the fourth quarter of 2026.
